Iga

RemeGen's Telitacicept (RC18) Granted Fast Track Designation by United States FDA for Treatment of Primary Sjögren's Syndrome

Retrieved on: 
Wednesday, April 3, 2024

The FDA grants FTD to accelerate the development and review of new drugs that have the potential to treat life-threatening conditions and address unmet medical needs.

Key Points: 
  • The FDA grants FTD to accelerate the development and review of new drugs that have the potential to treat life-threatening conditions and address unmet medical needs.
  • Telitacicept prevents abnormal differentiation and maturation of B-cells through a two-pronged approach, thereby treating various autoimmune diseases mediated by B-cells.
  • In December 2023, Telitacicept was granted Investigational New Drug (IND) by the FDA for the treatment of active pSS in adults.
  • Dr. Jianmin Fang, CEO of RemeGen, commented, "As the first fusion protein drug of its kind independently developed by RemeGen, we are delighted the FDA has recognized Telitacicept for fast track designation.

Bahrain Data Center Market Investment Analysis Report 2023-2028: Opportunities for Existing and Upcoming Facilities in IT, Electrical, Mechanical Infrastructure, Construction, and Tier Standards - ResearchAndMarkets.com

Retrieved on: 
Monday, November 20, 2023

The "Bahrain Data Center Market - Investment Analysis & Growth Opportunities 2023-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Bahrain Data Center Market - Investment Analysis & Growth Opportunities 2023-2028" report has been added to ResearchAndMarkets.com's offering.
  • The Bahrain data center market is expected to reach a value of 305.9 million by 2028 from $166.4 million in 2022, growing at a CAGR of 10.68% from 2022-2028
    This report analyses the Bahrain data center market share.
  • In the Bahrain data center market, Manama is a significant location for data center development; Hamala is also emerging as a new location for development.
  • The Bahrain data center market is witnessing investments from new entrants, which includes the Middle Eastern major colocation operator Gulf Data Hub.

Bahrain Data Center Market Investment and Opportunity Analysis Report 2023-2028: Focus on Manama, 3+ Unique Data Center Properties, IT Load Capacity, White Floor Area Space, Capacity by Cities

Retrieved on: 
Friday, November 24, 2023

DUBLIN, Nov. 24, 2023 /PRNewswire/ -- The "Bahrain Data Center Market - Investment Analysis & Growth Opportunities 2023-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Nov. 24, 2023 /PRNewswire/ -- The "Bahrain Data Center Market - Investment Analysis & Growth Opportunities 2023-2028" report has been added to ResearchAndMarkets.com's offering.
  • The Bahrain data center market is expected to reach a value of 305.9 million by 2028 from $166.4 million in 2022, growing at a CAGR of 10.68% from 2022-2028
    This report analyses the Bahrain data center market share.
  • In the Bahrain data center market, Manama is a significant location for data center development; Hamala is also emerging as a new location for development.
  • The Bahrain data center market is witnessing investments from new entrants, which includes the Middle Eastern major colocation operator Gulf Data Hub.

Infosys Welcomes Tennis World No.1 Iga Świątek as Global Brand Ambassador to Promote Infosys' Digital Innovation and Inspire Women Around the World

Retrieved on: 
Friday, August 25, 2023

She has bettered her skills and capabilities in the face of every new challenge to rise to the top.

Key Points: 
  • She has bettered her skills and capabilities in the face of every new challenge to rise to the top.
  • Infosys has helped reimagine tennis for over eight years as the digital innovation partner for the ATP Tour, Roland-Garros, Australian Open, and The International Tennis Hall of Fame.
  • The company has transformed the experience of the game for the tennis ecosystem leveraging advanced digital technologies like artificial intelligence (AI), cloud, and data analytics.
  • Iga Świątek, said, "I am delighted to collaborate with an organization like Infosys that's bringing their knowledge of technology to change the tennis experience for so many people.

Infosys Welcomes Tennis World No.1 Iga Świątek as Global Brand Ambassador to Promote Infosys' Digital Innovation and Inspire Women Around the World

Retrieved on: 
Friday, August 25, 2023

She has bettered her skills and capabilities in the face of every new challenge to rise to the top.

Key Points: 
  • She has bettered her skills and capabilities in the face of every new challenge to rise to the top.
  • Infosys has helped reimagine tennis for over eight years as the digital innovation partner for the ATP Tour, Roland-Garros, Australian Open, and The International Tennis Hall of Fame.
  • The company has transformed the experience of the game for the tennis ecosystem leveraging advanced digital technologies like artificial intelligence (AI), cloud, and data analytics.
  • Iga Świątek, said, "I am delighted to collaborate with an organization like Infosys that's bringing their knowledge of technology to change the tennis experience for so many people.

NuVasive Launches Reline Cervical for Posterior Cervical Fusion as Part of the C360 Portfolio

Retrieved on: 
Wednesday, September 28, 2022

SAN DIEGO, Sept. 28, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the commercial launch of Reline® Cervical, a new fixation system for posterior cervical fusion (PCF), in targeted regions.

Key Points: 
  • "Reline Cervical completes the foundational three strategic pillars of C360 anterior cervical decompression and fusion, cervical total disc replacement, and now PCF.
  • As cervical spine procedures comprise an approximately$2.6 billionsubsegment of the global spine market, the introduction of Reline Cervical will allow the Company's C360 portfolio to take even more share.
  • The compatibility of Reline Cervical with Pulse gives surgeons the benefits of navigation, imaging enhancement, intraoperative neuromonitoring, iGA, and patient-specific rod bending.
  • The expansion of the C360 portfolio further supports a comprehensive anterior and posterior offering of instrumentation, implants, biologic materials, and enabling technologies for any cervical procedure.